Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Genes and Immunity|November 9, 2002
Differential regulation of interleukin-10 production by genetic and environmental factors--a twin studyE Reuss, R Fimmers, A Kruger, et al.
Translational Lung Cancer Research|March 4, 2022
Use of on-therapy ctDNA monitoring in a patient with <i>KIF5B-RET</i> fusion positive advanced non-small cell lung cancer: a case reportVincent Yeung, Chul Kim, Lesli A Kiedrowski, et al.
Neuro-Oncology|October 31, 2008
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cellsMarkus D Siegelin, David E Reuss, Antje Habel, et al.
The Journal of Family Practice|December 5, 2017
Subacute loss of vision in one eye · rash on hands and feet · plaques with scaling on genitals · Dx?Abigail Nunn, Jeffrey M Sturek, Joshua E Reuss, et al.
Molecular Cancer Therapeutics|November 13, 2008
The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivinMarkus D Siegelin, David E Reuss, Antje Habel, et al.
JTO Clinical and Research Reports|April 14, 2025
Discordant Response to Nivolumab Plus Ipilimumab and Identification of <i>BRAF</i> V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case ReportOlivia Wilkins, Adedamola Omogbehin, Peter J Bergquist, et al.
JAMA Oncology|November 17, 2022
Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A ReviewAakash P Desai, Jacob J Adashek, Joshua E Reuss, et al.
Plos One|February 26, 2013
Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROSDavid E Reuss, Jana Mucha, Christian Hagenlocher, et al.
Neuroscience Letters|July 19, 2008
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivinT Gaiser, M R Becker, A Habel, et al.
Clinical Lung Cancer|July 7, 2023
Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsMatthew Z Guo, Aanika Balaji, Joseph C Murray, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Genes and Immunity|November 9, 2002
Differential regulation of interleukin-10 production by genetic and environmental factors--a twin studyE Reuss, R Fimmers, A Kruger, et al.
Translational Lung Cancer Research|March 4, 2022
Use of on-therapy ctDNA monitoring in a patient with <i>KIF5B-RET</i> fusion positive advanced non-small cell lung cancer: a case reportVincent Yeung, Chul Kim, Lesli A Kiedrowski, et al.
Neuro-Oncology|October 31, 2008
Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cellsMarkus D Siegelin, David E Reuss, Antje Habel, et al.
The Journal of Family Practice|December 5, 2017
Subacute loss of vision in one eye · rash on hands and feet · plaques with scaling on genitals · Dx?Abigail Nunn, Jeffrey M Sturek, Joshua E Reuss, et al.
Molecular Cancer Therapeutics|November 13, 2008
The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivinMarkus D Siegelin, David E Reuss, Antje Habel, et al.
JTO Clinical and Research Reports|April 14, 2025
Discordant Response to Nivolumab Plus Ipilimumab and Identification of <i>BRAF</i> V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case ReportOlivia Wilkins, Adedamola Omogbehin, Peter J Bergquist, et al.
JAMA Oncology|November 17, 2022
Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A ReviewAakash P Desai, Jacob J Adashek, Joshua E Reuss, et al.
Plos One|February 26, 2013
Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROSDavid E Reuss, Jana Mucha, Christian Hagenlocher, et al.
Neuroscience Letters|July 19, 2008
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivinT Gaiser, M R Becker, A Habel, et al.
Clinical Lung Cancer|July 7, 2023
Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint InhibitorsMatthew Z Guo, Aanika Balaji, Joseph C Murray, et al.
Pageof 14